Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Sheldon Sloan currently holds 87,542 shares of Spyre Therapeutics, Inc. (SYRE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sheldon Sloan has been a net seller of SYRE stock. They have purchased $0 and sold $397.9K worth of shares.
Sheldon Sloan's most recent insider trade was on Apr 1, 2026, when they sold 7,958 shares at $0.00 per share.
Sheldon Sloan serves as Executive at Spyre Therapeutics, Inc. (SYRE). They have executed 5 insider transactions totaling $397.9K over their tenure at the company.
Sheldon Sloan holds the position of Executive at Spyre Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Sheldon Sloan has shown a selling trading pattern, with $0 in total purchases and $397.9K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Sheldon Sloan was on Apr 1, 2026, when they sold $397.9K worth of SYRE shares. This transaction involved 7,958 shares at $50.00 per share.
Sheldon Sloan currently owns 87,542 shares of Spyre Therapeutics, Inc. (SYRE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Sheldon Sloan's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Sheldon Sloan has 5 Form 4 filings on record as an insider at Spyre Therapeutics, Inc..
Set alerts for Sheldon Sloan and 40,000+ other insiders.